NextDocs Joins the PAREXEL Perceptive® Partner Program to Expand Enterprise Content Management Footprint in Life Sciences

CONSHOHOCKEN, Pa., Nov. 17, 2014 /PRNewswire/ -- NextDocs Corporation, a leading provider of regulated content management and compliance solutions for the life sciences industry, today announced the company has joined the PAREXEL Perceptive® Partner Program.  As a member, NextDocs will enhance and broaden its services to biopharmaceutical customers by leveraging thePerceptive MyTrials® eClinical platform, one of the industry's leading suites of applications for managing clinical trials. 

Under the agreement, both NextDocs and PAREXEL Informatics have entered into an integration agreement that will strengthen the offerings of both organizations. NextDocs will utilize its open and extensible architecture to integrate with the Perceptive suite of technology solutions, specifically IMPACT® CTMS and LIQUENT InSight®

"Through the NextDocs/PAREXEL Informatics integration partnership, our mutual clients are anticipated to benefit from the sharing of critical metadata and documents among IMPACT CTMS, LIQUENT InSight and NextDocs, giving them improved access to vital eClinical metrics," said Graham Bunn, Vice President, Perceptive Partner Program. "The expected result is an improvement in decision-making capabilities and a reduction in the manual processes for our clients."

With its market-leading NextDocs 6 eTMF solution and Investigator Portal offering called Trial Exchange (TrX), NextDocs currently manages over 1 million regulatory documents for well over 500 clinical trials for organizations such as PRA, AstraZeneca, Sanofi, Sandoz and Covance. The Perceptive MyTrials® suites of applications allows partners to integrate targeted, specialized solutions within the platform. This gives their sponsor customers efficient access to clinical data and applications from a single source, with the aim of allowing them to more efficiently and effectively manage critical trial activities.

"By joining the Perceptive® Partner Program, NextDocs continues its commitment to providing a robust, integrated solution set to assist in solving the challenges faced by life sciences organizations," said Ephraim Peak, Vice President of Global Alliances at NextDocs. "Integration between clinical trial management solutions and comprehensive eClinical platforms such as Perceptive MyTrials® is considered a paramount requirement for the industry and our customer base. Alignment with PAREXEL Informatics positions NextDocs to deliver that promise to our customers."

About NextDocs 
NextDocs is the global leader in providing regulated content management and compliance solutions to life sciences organizations. NextDocs provides solutions for electronic trial master files (eTMF), regulatory submissions, standard operating procedures (SOP) and quality management systems (QMS). These solutions enable businesses in highly regulated industries to achieve compliance with the FDA and other agencies while automating processes, improving efficiency and dramatically reducing costs. NextDocs has delivered over 100 deployments with FDA regulated customers including five of the ten largest pharmaceutical companies and two of the largest clinical research organizations (CROs). NextDocs has won numerous awards including the Microsoft Life Sciences Partner of the Year award four years in a row. All NextDocs solutions are 100% browser-based and can be deployed in the cloud or on-premises. For more information visit www.nextdocs.com, or follow us on LinkedIn and Twitter.

About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics, Inc. provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 81 locations in 51 countries around the world, and has approximately 15,980 employees.  For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL, PAREXEL Informatics, Perceptive, and Perceptive MyTrials are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates.

Contact: Che Dildy 
Tel. +1 610-265-9474 
Email: [email protected]

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.